SIRT1 and Cirrhosis: So, it is noteworthy to explore the effects of the administration of a highly absorbed intestinal SIRT1 activator such as resveratrol on the coexisting TNFα-mediated intestinal and renal pathogenic changes as well as renal dysfunction in cirrhosis.